An Open-label, Randomized, 2-Period, Crossover Study to Assess the Comparative Pharmacokinetics of LSP-5415 and NuvaRing in Healthy Adult Females
Latest Information Update: 22 Jul 2022
At a glance
- Drugs Ethinylestradiol/etonogestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Lupin Pharmaceuticals
Most Recent Events
- 18 Jul 2022 Status changed from active, no longer recruiting to completed.
- 12 May 2022 New trial record